SAFE-PLASMA Protocol
Subject: SAFE-PLASMA ProtocolSolicitation Number: HT9427-27-SSN-701Notice Type: SRCSGTNAICS: 541715Notice Published: 11-10-26Response Due: 11-16-26Agency: Other Defense AgenciesOffice: Defense Health AgencyContact: Jamie Diggs This email address is being protected from spambots. You need JavaScript enabled to view it.Office Address: FORT DETRICK, MD 21702Place of Performance: MD 21702
Click for official SAM (FBO) notice, additional information, and accompanying attachments
The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration?s requirements for EZPLAZ? approval.